Common use of Use of Trademarks and House Marks Clause in Contracts

Use of Trademarks and House Marks. The Joint Steering Committee will determine which Trademark or Trademarks will be used in marketing Product in the Territory. Further, all packaging, and package inserts for Product in the Territory shall, along with the GSK brand name and logo or other identifying markings of GSK or its Affiliates (collectively, the “GSK House Marks”), include the Amicus brand name and logo (such Amicus brand name and logo, collectively “Amicus House Marks”) in reasonable size and prominence as allowed by applicable Law; it being understood that the exact size, placement and prominence of such Amicus House Marks shall be determined by GSK in its reasonable discretion. Amicus hereby grants to GSK a non-exclusive, royalty-free license, with the right to grant sublicenses as provided in Section 2.2, to use the Amicus House Marks in connection with the developing, making, having made, use, sale, offering for sale, importation, packaging, distributing and promotion of the Products in the Field in the Territory. The ownership and all goodwill from the use of the Amicus House Marks shall vest in and inure to the benefit of Amicus. Solely to the extent necessary to preserve Xxxxxx’s legal rights in the Amicus House Marks, GSK shall submit to Amicus, not less than fifteen (15) days prior to their proposed distribution, representative packaging for the Product displaying the Amicus House Marks for Xxxxxx’s review and written approval solely with respect to GSK’s use of the Amicus House Marks, which approval will not be unreasonably withheld or delayed. If Xxxxxx has not responded within thirty (30) days after the submission of such packaging for the Product, Xxxxxx’s approval to GSK’s use of the Amicus House Marks on such packaging will be deemed to have been received. GSK may make any subsequent changes to packaging bearing the Amicus House Marks, other than changes to the Amicus House Marks, without the subsequent approval from Amicus.

Use of Trademarks and House Marks. The Joint Steering Committee will determine which Trademark or Trademarks will be used in marketing Product in the Territory. Further, all packaging, and package inserts for Product in the Territory shall, along with the GSK brand name and logo or other identifying markings of GSK or its Affiliates (collectively, the “GSK House Marks”), include the Amicus brand name and logo (such Amicus brand name and logo, collectively “Amicus House Marks”) in reasonable size and prominence as allowed by applicable Law; it being understood that the exact size, placement and prominence of such Amicus House Marks shall be determined by GSK in its reasonable discretion. Amicus hereby grants to GSK a non-exclusive, royalty-free license, with the right to grant sublicenses as provided in Section 2.2, to use the Amicus House Marks in connection with the developing, making, having made, use, sale, offering for sale, importation, packaging, distributing and promotion of the Products in the Field in the Territory. The ownership and all goodwill from the use of the Amicus House Marks shall vest in and inure to the benefit of Amicus. Solely to the extent necessary to preserve XxxxxxAmicus’s legal rights in the Amicus House MarksXxxxxx Xxxxx Xxxxx, GSK XXX shall submit to Amicus, not less than fifteen (15) days prior to their proposed distribution, representative packaging for the Product displaying the Amicus House Marks for XxxxxxAmicus’s review and written approval solely with respect to GSK’s use of the Amicus House Marks, which approval will not be unreasonably withheld or delayed. If Xxxxxx Amicus has not responded within thirty (30) days after the submission of such packaging for the Product, XxxxxxAmicus’s approval to GSK’s use of the Amicus House Marks on such packaging will be deemed to have been received. GSK may make any subsequent changes to packaging bearing the Amicus House Marks, other than changes to the Amicus House Marks, without the subsequent approval from Amicus.

Use of Trademarks and House Marks. The Joint Steering Committee will determine which Trademark or Trademarks will be used in marketing Product Products and Additional Products in the Territory. Further, all packaging, and package inserts for Product the Products in the Collaboration Territory shall, along with the GSK brand name and logo or other identifying markings of GSK or its Affiliates (collectively, the “GSK House Marks”), include the Amicus VALEANT brand name and logo (such Amicus VALEANT brand name and logo, collectively “Amicus VALEANT House Marks”) in reasonable size and prominence as allowed by applicable Law; it being understood that the exact size, placement and prominence of such Amicus VALEANT House Marks shall be determined by GSK in its reasonable discretion. Amicus VALEANT hereby grants to GSK a non-exclusive, royalty-free license, with the right to grant sublicenses as provided in Section 2.21.3, to use the Amicus VALEANT House Marks in connection with the developing, developing making, having made, use, sale, offering for sale, importation, packaging, distributing and promotion of the Products Product in the Field in the Collaboration Territory. The ownership and all goodwill from the use of the Amicus House Marks shall vest in and inure to the benefit of Amicus. Solely to the extent necessary to preserve XxxxxxVALEANT’s legal rights in the Amicus House MarksXXXXXXX Xxxxx Xxxxx, GSK XXX shall submit to AmicusVALEANT, not less than fifteen (15) days prior to their proposed distribution, representative packaging for the Product displaying the Amicus VALEANT House Marks to VALEANT for XxxxxxVALEANT’s review and written approval solely with respect to GSK’s use of the Amicus VALEANT House Marks, which approval will not be unreasonably withheld or delayed. If Xxxxxx VALEANT has not responded within thirty (30) days after the submission of such packaging for the Product, XxxxxxVALEANT’s approval to GSK’s use of the Amicus VALEANT House Marks on such packaging and will be deemed to have been received. GSK may make any subsequent changes to packaging bearing the Amicus VALEANT House Marks, other than changes to the Amicus VALEANT House Marks, Marks without the subsequent approval from AmicusVALEANT. For clarity, only GSK House Marks will be used on Products in the GSK Territory and Additional Products in the Territory.

Use of Trademarks and House Marks. 6.3.1 The Joint Commercialization Subcommittee will determine, and the Joint Steering Committee will determine confirm, which GSK Trademark or GSK Trademarks will be used in marketing Products in the GSK Territory and the Amicus Territory, with the goal of identifying a global GSK Trademark for each Product that may be used in the Amicus Territory and throughout the GSK Territory. In the event that a GSK Trademark selected by the Joint Commercialization Subcommittee and Joint Steering Committee is not registerable in the Amicus Territory or throughout the GSK Territory, or is not approved by the applicable Regulatory Authorities for a Product in a country in the Territory, the Joint Commercialization Subcommittee shall have the right to select (subject to approval by the Joint Steering Committee) an alternative GSK Trademark for use in connection with such Product in such country, it being understood that the Parties shall mutually agree upon the pool of alternative GSK Trademarks for such purposes. Further, all packaging, Neither Party shall have the right to select and use a Trademark or a GSK Trademark in connection with a Product without the prior written consent and approval of the Joint Commercialization Subcommittee and the Joint Steering Committee. All packaging and package inserts for Product in the GSK Territory shall, along with will include the GSK brand name and logo or other identifying markings of GSK or its Affiliates (collectively, the “GSK House Marks”), and all packaging and package inserts for Product in the Amicus Territory will include the Amicus brand name and logo (such Amicus brand name and logo, or other identifying markings of ****** - Material has been omitted and filed separately with the Commission. Amicus (collectively “Amicus House Marks”) in reasonable size and prominence as allowed by applicable Law; it being understood that the exact size, placement and prominence of such Amicus House Marks shall be determined by GSK in its reasonable discretion. Amicus hereby grants to GSK a non-exclusive, royalty-free license, with the right to grant sublicenses as provided in Section 2.2, to use the Amicus House Marks in connection with the developing, making, having made, use, sale, offering for sale, importation, packaging, distributing and promotion of the Products in the Field in the Territory. The ownership and all goodwill from the use of the Amicus House Marks shall vest in and inure to the benefit of Amicus. Solely to the extent necessary to preserve Xxxxxx’s legal rights in the Amicus House Marks, GSK shall submit to Amicus, not less than fifteen (15) days prior to their proposed distribution, representative packaging for the Product displaying the Amicus House Marks for Xxxxxx’s review and written approval solely with respect to GSK’s use of the Amicus House Marks, which approval will not be unreasonably withheld or delayed. If Xxxxxx has not responded within thirty (30) days after the submission of such packaging for the Product, Xxxxxx’s approval to GSK’s use of the Amicus House Marks on such packaging will be deemed to have been received. GSK may make any subsequent changes to packaging bearing the Amicus House Marks, other than changes to the Amicus House Marks, without the subsequent approval from Amicus.